Mesoblast COVID-19 therapy granted fast-track designation

Mesoblast’s lead drug candidate to treat COVID-19 has been granted fast track designation from the United States Food and Drug … Read More

The post Mesoblast COVID-19 therapy granted fast-track designation appeared first on Stockhead.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *